Inventor
SHUTTLEWORTH STEPHEN JOSEPH
GB24 patents
⚠️ This page may combine multiple inventors who share the name “SHUTTLEWORTH STEPHEN JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KARUS THERAPEUTICS LTD
11 patentsUS10513530B2Dec 24, 2019
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
KARUS THERAPEUTICS LTD5 citations83
US10035785B2Jul 31, 2018
Phosphoinositide 3-kinase inhibitors
KARUS THERAPEUTICS LTD10 citations83
US9981987B2May 29, 2018
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
KARUS THERAPEUTICS LTD11 citations83
US9663487B2May 30, 2017
Phosphoinositide 3-kinase inhibitors
KARUS THERAPEUTICS LTD13 citations83
US10501478B2Dec 10, 2019
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
KARUS THERAPEUTICS LTD5 citations82
US9340503B2May 17, 2016
Scriptaid isosteres and their use in therapy
KARUS THERAPEUTICS LTD7 citations81
US11291669B2Apr 5, 2022
Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent
KARUS THERAPEUTICS LTD4 citations69
US10668077B2Jun 2, 2020
Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent
KARUS THERAPEUTICS LTD4 citations69
US10407435B2Sep 10, 2019
Diheteroaryl histone deacetylase inhibitors and their use in therapy
KARUS THERAPEUTICS LTD6 citations69
US10377764B2Aug 13, 2019
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
KARUS THERAPEUTICS LTD5 citations66
US10533003B2Jan 14, 2020
Polyheteroarl histone deacetylase inhibitors and their use in therapy
KARUS THERAPEUTICS LTD1 citations59
SHUTTLEWORTH STEPHEN JOSEPH
5 patentsUS9266879B2Feb 23, 2016
Naphthridine derivatives as PI3K inhibitors for the treatment of cancer and immune-inflammatory disease
SHUTTLEWORTH STEPHEN JOSEPH21 citations91
US9200007B2Dec 1, 2015
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
SHUTTLEWORTH STEPHEN JOSEPH22 citations90
US8981087B2Mar 17, 2015
Benzo [E] [1,3] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
SHUTTLEWORTH STEPHEN JOSEPH26 citations90
US8748458B2Jun 10, 2014
Scriptaid isosteres and their use in therapy
SHUTTLEWORTH STEPHEN JOSEPH8 citations81
US8614193B2Dec 24, 2013
Depsipeptides and their therapeutic use
SHUTTLEWORTH STEPHEN JOSEPH0 citations39
CONVALIFE SHANGHAI CO LTD
3 patentsUS11708378B2Jul 25, 2023
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
CONVALIFE SHANGHAI CO LTD2 citations71
US11779586B2Oct 10, 2023
Compounds comprising tricyclic heterocyclic compounds
CONVALIFE SHANGHAI CO LTD2 citations67
US12257254B2Mar 25, 2025
Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent
CONVALIFE SHANGHAI CO LTD0 citations57